How The FDA Treats A Supplement Compared With A Drug

An Ayurvedic capsule and a prescription tablet sold in the same American pharmacy sit under entirely different regulatory regimes. The difference concerns what must be proven, by whom, and at what point.

What a drug has to establish

A prescription drug requires approval before it can be sold, and that approval rests on data from controlled trials submitted by the manufacturer and reviewed by the agency.

The manufacturer must demonstrate both effectiveness for a stated indication and an acceptable safety profile, and the labelling that results is itself approved.

Manufacturing is inspected against detailed standards, and post-approval reporting of adverse events is mandatory rather than voluntary.

What a supplement has to establish

Dietary supplements require no premarket approval. A product containing ingredients already in the food supply can be sold without any efficacy or safety review.

The manufacturer is responsible for ensuring its product is safe and its labelling truthful, and the agency's role is largely to act after a problem appears.

Manufacturing rules do apply, covering identity, purity and record-keeping, but compliance is checked through inspection rather than established before sale.

Why the categories were separated

Federal law in the 1990s created the supplement category explicitly, placing these products closer to food than to medicine in the regulatory structure.

The reasoning was that substances with long histories of dietary use should not face the burden designed for novel pharmaceutical compounds.

The consequence is a large market of products making health-adjacent claims without the evidence base that a drug claim would require.

What the claim rules permit

Supplements may make claims about affecting the structure or function of the body, but they may not claim to diagnose, treat, cure or prevent a disease.

Structure and function claims must carry a disclaimer stating that the agency has not evaluated them, which is the fine print familiar on every bottle.

Crossing into disease claims is what most commonly triggers enforcement, and warning letters over such claims are issued regularly and published.

What this means for reading a product

Presence on a shelf establishes nothing about whether a product works, and it establishes considerably less about safety than most buyers assume.

It also means the burden of evaluation falls on the buyer, which is why independent testing and species identification matter so much in this category.

Anyone using supplements alongside prescribed medication should tell their physician and pharmacist, since interaction checking depends on knowing what is being taken.